Blarcamesine
Based on 3 publication(s) in Google Scholar
Blarcamesine is an orally bioavailable Sigma-1 receptor agonist and muscarinic receptor modulator, with anticonvulsant, anti-amnesic, neuroprotective and antidepressant properties. Blarcamesine ameliorates neurologic impairments in a mouse model of Rett syndrome.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.16%
- CAS No.: 195615-83-9
- Formule: C19H23NO
- Masse moléculaire:281.39
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
Neurotransmitter Receptor Compound Library
HY-L062
-
Neuroprotective Compound Library
HY-L070
-
Anti-Parkinson's Disease Compound Library
HY-L085
-
Neurodegenerative Disease-related Compound Library
HY-L086
-
Rare Diseases Drug Library
HY-L102
-
Antidepressant Compound Library
HY-L108
-
Heterocyclic Compound Library
HY-L138
-
Membrane Protein-targeted Compound Library
HY-L149
-
Membrane Receptor-targeted Compound Library
HY-L150
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Drug Repurposing Compound Library Plus
HY-L035P
-
Clinical Compound Library Plus
HY-L026P
-
Bioactive Compound Library
HY-L001
-
High-Throughput Bioactive Compound Library
HY-L205
-
Lactylation Compound Library
HY-L249
-
GPCR/G Protein Compound Library
HY-L006
-
Neuronal Signaling Compound Library
HY-L013
-
Anti-Cancer Compound Library
HY-L025
-
Clinical Compound Library
HY-L026
-
Drug Repurposing Compound Library
HY-L035
Publications Citing Use of MedChemExpress (MCE) Blarcamesine
MoreVoir tous les produits spécifiques à Isoform Sigma Receptor
More
Activité biologique
|
Sigma 1 Receptor |
Blarcamesine ameliorates acoustic startle deficit in Mecp2 HET mice[1].
Blarcamesine reverses deficits in visual acuity in older Mecp2 HET mice using the optokinetic response[1].
Blarcamesine produces minimal effects on body weight gain in Mecp2 HET mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female Mecp2tm1.1Bird/J HET (C57 background) mice[1]
-
Dosage:10 mg/kg, 30 mg/kg
-
Administration:Oral administration, daily, for 6.5 weeks
-
Result:Reverse the deficits observed in the HET animals.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 195615-83-9
-
Appearance Solid
-
Masse moléculaire 281.39
-
Formule C19H23NO
-
Color White to off-white
-
SMILES
CN(C)CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)OCC1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Arch Toxicol
2024 Oct;98(10):3323-3336. PMID: 38896176 -
Food Chem Toxicol
Lonp1 and Sig-1R contribute to the counteraction of ursolic acid against ochratoxin A-induced mitochondrial apoptosis. [Abstract]2023 Feb:172:113592. PMID: 36587836 -
Solvant et solubilité
DMSO : 116.67 mg/mL (414.62 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (281 KB)
-
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Korean - KR (254 KB)
- Portuguese - PT (254 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.5538 mL | 17.7689 mL | 35.5379 mL | 88.8447 mL |
| 5 mM | 0.7108 mL | 3.5538 mL | 7.1076 mL | 17.7689 mL | |
| 10 mM | 0.3554 mL | 1.7769 mL | 3.5538 mL | 8.8845 mL | |
| 15 mM | 0.2369 mL | 1.1846 mL | 2.3692 mL | 5.9230 mL | |
| 20 mM | 0.1777 mL | 0.8884 mL | 1.7769 mL | 4.4422 mL | |
| 25 mM | 0.1422 mL | 0.7108 mL | 1.4215 mL | 3.5538 mL | |
| 30 mM | 0.1185 mL | 0.5923 mL | 1.1846 mL | 2.9615 mL | |
| 40 mM | 0.0888 mL | 0.4442 mL | 0.8884 mL | 2.2211 mL | |
| 50 mM | 0.0711 mL | 0.3554 mL | 0.7108 mL | 1.7769 mL | |
| 60 mM | 0.0592 mL | 0.2961 mL | 0.5923 mL | 1.4807 mL | |
| 80 mM | 0.0444 mL | 0.2221 mL | 0.4442 mL | 1.1106 mL | |
| 100 mM | 0.0355 mL | 0.1777 mL | 0.3554 mL | 0.8884 mL |
Blarcamesine Related Classifications
HY-105296 Related Classifications
Powered by Bioz